Theranos: The Blood Test That Couldn't Test Blood
Theranos promised to replace the lab and democratize diagnosis; instead, it built a billion-dollar illusion on secrecy, prestige, and machines that could not do what the company claimed. How long can a fraud survive when the blood is the evidence?
Quick Facts
- Period
- 2003 - 2018
- Region
- Americas
- Key Figures
- Elizabeth Holmes, John Carreyrou, Richard M. Fuisz +2 more
Key Figures
Elizabeth Holmes
Perpetrator
Theranos co-founder and former CEOElizabeth Holmes built herself as a contradiction and then learned to live inside it. She sold austerity as destiny, spe...
John Carreyrou
Investigator
Wall Street Journal reporterJohn Carreyrou matters to the Theranos story because he forced the company’s claims into daylight. As a Wall Street Jour...
Richard M. Fuisz
Enabler / Victim
Theranos patent dispute adversary and physician-inventorRichard M. Fuisz occupies a more complicated place in the Theranos record than many of the company’s named adversaries. ...
Sunny Balwani
Perpetrator
Theranos president and chief operating officerSunny Balwani occupies a different place in the Theranos story: less mythic than Elizabeth Holmes, less visible to the p...
Tyler Shultz
Whistleblower
Former Theranos employee and grandson of board member George ShultzTyler Shultz stands as one of the most revealing figures in the Theranos collapse because his significance is not rooted...
The Story
This narrative combines documented history with dramatized scenes for storytelling purposes.
Origins & The Setup
Elizabeth Holmes did not begin as a con artist in the caricatured sense of a person arriving fully formed with a scheme. She was a Stanford dropout with an engi...
The Pitch & The Pull
The pitch became persuasive because it did more than describe a product. It offered a moral rearrangement of medicine. Theranos told investors, pharmacists, and...
The Mechanics of the Lie
Once Theranos moved from promise to production, the fraud became an operation. It needed paperwork, routing decisions, supportive vendors, and constant curation...
The Unraveling
The unraveling began not with a single dramatic reveal but with pressure from several directions at once. One of the most consequential triggers was investigati...
Aftermath & Legacy
After the charges came the long, public accounting. In federal court in San Jose, the Holmes trial became more than a verdict on one executive’s conduct; it bec...
Timeline
Theranos is founded
**2003** — Elizabeth Holmes incorporates Theranos while still a teenager after leaving Stanford. The company is built around the claim that blood testing can be miniaturized and made far cheaper than the laboratory model then in use.
The retail health pitch reaches major investors
**2009-01** — Theranos presents itself as a breakthrough diagnostics company to venture backers and strategic partners. The pitch emphasizes finger-stick testing and a future in which lab work becomes faster, cheaper, and less invasive.
Walgreens partnership expands public reach
**2013-09** — Theranos begins placing testing services in Walgreens locations, turning a startup narrative into a consumer-facing healthcare product. The move gives the company legitimacy and exposes more patients to its claims.
Wall Street Journal investigation challenges the technology
**2015-10-16** — John Carreyrou's reporting questions whether Theranos is using its own devices for the tests it advertises. The story becomes a turning point by moving suspicion into the public record.
CMS inspection reveals major lab problems
**2015-10** — Federal inspectors examine Theranos laboratories and identify serious quality-control issues. The findings threaten the company’s laboratory certification and undermine its public claims.
Theranos shuts down its clinical labs and voids results
**2016-07** — After regulatory action, Theranos halts testing at its Newark laboratory and later voids thousands of test results that had been issued from the site. The company’s medical credibility begins to collapse in public.
SEC files civil fraud charges
**2018-03-14** — The Securities and Exchange Commission brings a civil complaint against Holmes and Balwani, alleging investor fraud and false claims about Theranos technology and revenue. The filing publicly names the company’s deception in legal form.
Federal criminal charges are announced
**2018-06-15** — The U.S. Department of Justice announces criminal charges against Holmes and Balwani. Prosecutors allege wire fraud and conspiracy in connection with investors, doctors, and patients.
Holmes trial begins
**2021-08-31** — Jury selection and opening proceedings start in Elizabeth Holmes's federal trial in San Jose. The case centers on whether she knowingly lied about Theranos's ability to perform blood tests as advertised.
Holmes is convicted on multiple fraud counts
**2022-01-03** — A federal jury finds Holmes guilty on four counts related to investor fraud. The verdict marks the formal collapse of the founder legend that had sustained Theranos for years.
Balwani is convicted
**2022-07-07** — A separate federal jury convicts Sunny Balwani on fraud charges tied to his role at Theranos. The verdict extends criminal responsibility beyond Holmes to the company’s operational center.
Sentencing concludes the criminal phase
**2023-11-18** — The federal court sentences Holmes to prison and imposes a term on Balwani as well. Theranos is long defunct, and the criminal case closes the main chapter of public accountability.
Sources
- court_documentSEC v. Theranos, Inc., Elizabeth Holmes, and Ramesh Balwani, Complaint
Primary civil fraud complaint filed by the SEC in 2018.
- government_releaseU.S. Department of Justice press release on charges against Holmes and Balwani
Announces criminal wire fraud and conspiracy charges.
- court_docketUnited States v. Elizabeth Holmes, Criminal Docket
Public docket for the federal criminal case.
- court_docketUnited States v. Ramesh Balwani, Criminal Docket
Public docket for the federal criminal case against Balwani.
- congressional_hearingU.S. House Committee on Energy and Commerce / Subcommittee hearing on Theranos
Congressional record and hearing materials on the company and diagnostics oversight.
- bookJohn Carreyrou, Bad Blood: Secrets and Lies in a Silicon Valley Startup
Primary-source reporting account by the Wall Street Journal reporter who broke the story.
- journalismWall Street Journal Theranos investigation, 2015
Initial investigative reporting that exposed major contradictions in Theranos's claims.
- journalismBloomberg reporting on Theranos and regulatory failures
Detailed follow-up coverage on the company's technology and collapse.
- journalismNew York Times coverage of Theranos trials and sentencing
Court reporting on verdicts, appeals, and sentencing.
- regulatory_recordCMS inspection and sanction records concerning Theranos laboratories
Documents the laboratory compliance findings that damaged the company’s operating license.
Explore Related Archives
Financial fraud has toppled companies, entangled governments, and exploited trust across borders. Explore the broader context through our sister archives.
